Table 2 Characteristics of patients with Kaposi sarcoma who were lost to follow-up in four countries in sub-Saharan Africa (N1a + D2 in Fig. 1)
| Â | AMPATH - Kenya NÂ =Â 233 | ISS - Uganda NÂ =Â 79 | Lighthouse - Malawi NÂ =Â 74 | UATH & NHA - Nigeria NÂ =Â 36 | Overall NÂ =Â 422 |
|---|---|---|---|---|---|
Age at last visit, years a | 35 (30–42)b | 32 (29–40) | 34 (29–40) | 36 (32–42) | 35 (29–41) |
Male sex a | 62% | 68% | 78% | 51% | 65% |
ART in use at last visit | 82% | 77% | 47% | 58% | 73% |
CD4+ T-cells /mm 3 at last visit c | 126 (39–287) | 183 (110–317) | 231 (141–387) | 259 (177–308) | 159 (60–312) |
CD4+ T-cells /mm 3 at last visit c , category | |||||
 0–50 | 28% | 17% | 6.7% | 7.7% | 22% |
 51–100 | 15% | 4.4% | 6.7% | 7.7% | 12% |
 101–200 | 23% | 30% | 27% | 23% | 24% |
 201–350 | 18% | 30% | 33% | 46% | 24% |
 351–500 | 9.4% | 13% | 20% | 0% | 10% |
  > 500 | 7.3% | 4.4% | 6.7% | 15% | 7.5% |
Duration since KS diagnosis at last visit, months | 0.96 (0–3.5) | 1.9 (0.3–4.7) | 1.9 (0–8.3) | 4.7 (0.6–18.1) | 1.4 (0.03–5.1) |
Duration of being lost at database closure, months | 17 (11–22) | 30 (19–39) | 31 (17–47) | 26 (14–46) | 21 (13–30) |